➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
AstraZeneca
Colorcon
Harvard Business School
Medtronic

Last Updated: July 28, 2021

DrugPatentWatch Database Preview

Details for Patent: 8,778,999


Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,778,999 protect, and when does it expire?

Patent 8,778,999 protects BROMSITE and is included in one NDA.

This patent has six patent family members in six countries.

Summary for Patent: 8,778,999
Title:Non-steroidal anti-inflammatory ophthalmic compositions
Abstract: The disclosure provides compositions and systems for topical ophthalmic application, which include an aqueous mixture of bromfenac and flowable mucoadhesive polymer, for treating inflammation and inflammatory conditions of the eye.
Inventor(s): Hosseini; Kamran (Los Altos, CA), Bowman; Lyle (Pleasanton, CA), Si; Erwin C. (Alameda, CA), Pham; Stephen (Sacramento, CA)
Assignee: Insite Vision Incorporated (Alameda, CA)
Application Number:12/398,657
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,778,999
Patent Claim Types:
see list of patent claims
Composition; Use;

Drugs Protected by US Patent 8,778,999

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sun Pharma Global BROMSITE bromfenac sodium SOLUTION/DROPS;OPHTHALMIC 206911-001 Apr 8, 2016 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y TREATMENT OF POSTOPERATIVE INFLAMMATION AND PREVENTION OF OCULAR PAIN IN PATIENTS UNDERGOING CATARACT SURGERY ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Merck
Mallinckrodt
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.